Clinical Trials in San Francisco

Showing 1341-1360 of 11,161 trials

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

NCT05929235

The goal of this clinical trial is to study the safety and tolerability in all advanced solid tumors, including advanced urothelial carcinoma. The main question\[s\] it aims to answer are: * Is FX-909 safe and tolerable, as a monotherapy and in combination with Pembrolizumab * What is the right dose level for patients Participants will be asked to take FX-909 daily in tablet form, or FX-909 daily and Pembrolizumab every 3 weeks, and record any outcomes from taking the drug. Participants will also be asked to return for multiple site visits for various blood tests and to collect blood and tumor samples as well as have regular CT/MRI scans.

Advanced Urothelial CarcinomaOral Drug AdministrationOpen Label

Flare Therapeutics Inc.120 participantsStarted Aug 2023

San Francisco, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +8 more locations

Active Not RecruitingPhase 4< 1 mile

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

NCT05757713

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who are \<8 years of age.

Diabetes Mellitus, Type 1

Sanofi20 participantsStarted Jul 2023

San Francisco, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +7 more locations

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Find Trials by Condition in San Francisco

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

CHEER Oral Health in Pregnancy Study

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Efficacy of Repeated Low-level Red-light Therapy in Myopia Control

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain

Transcranial Magnetic Stimulation for the Treatment of Veterans With Alcohol Use Disorders

Fetal Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

A Study of PHN-010 in Patients With Advanced Solid Tumors

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery